Related Post

12 Comments Received

Wednesday 16th June 2010 02:56:27 PM

Biovail believes that there is considerable opportunity for a tramadol and acetaminophen product line offering that includes Ralivia ER(TM) intended for chronic use and oral disintegrating tablet presentations of tramadol and tramadol/acetaminophen for the treatment of acute pain.

Monday 21st June 2010 10:21:05 AM

26, 2004 Biovail Corporation (NYSE:BVF) (TSX:BVF): -- Conducting out-licensing discussions with multiple partners -- Flashtab immediate-release tramadol NDA submission expected H1 2004 -- Acquires rights to tramadol/acetaminophen formulation from Ethypharm -- Biovail/Ethypharm Shareholders Agreement modified -- Biovail reacquires North American rights to Diltiazem CR from Ethypharm Biovail Corporation (NYSE:BVF) (TSX:BVF) announced today that it has received confirmation, with an effective date of February 29, 2004, for the filing of its December 31, 2003 submission for a New Drug Application (NDA) to the Food and Drug Administration (FDA) for Ralivia ER(TM) (tramadol hydrochloride) Extended Release tablets.

Tuesday 22nd June 2010 12:07:29 AM

As a result of these initiatives, the elimination of Biovail's financing commitment to Ethypharm removes a contingent obligation, simplifies reporting and provides enhanced transparency.

Tuesday 22nd June 2010 09:30:36 PM

(TSX: DDS; NASDAQ: DDSS) today reported its results for tramadol and acetaminophen the first quarter ended March 31, 2008.

Monday 14th June 2010 09:05:30 PM

Patients were randomized to receive an Tramadol and acetaminophen initial single dose of one to two pills of tramadol/acetaminophen or placebo at the first sign of an osteoarthritis flare.

Wednesday 23rd June 2010 05:12:25 PM

Tramadol Tramadol and acetaminophen versus hydrocodone-acetaminophen in acute musculoskeletal pain: a randomized, double-blind clinical trial.

Saturday 26th June 2010 08:16:55 PM

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies.

Saturday 3rd July 2010 06:02:34 AM

Ralivia ER(TM) uses Biovail's Smartcoat Technology, which is similar to that used in the development of tramadol and acetaminophen biovail's Wellbutrin XL formulation.

Leave A Reply

Please Note: Comments maybe under moderation after you submit your comments so there is no need to resubmit your comment again